Test article | Total dose | Week 13 of the experimental period | Week 104 of the experimental period | ||||
---|---|---|---|---|---|---|---|
(mg/kg) | (μg/animal) | (μg/g lung) | (μg/animal) | (μg/g lung) | |||
Control | 0 | (5) | – | – | – | – | |
MWNT-7 | 0.128 | (5) | 19.7 ± 2.50 | 15.5 ± 2.6 | (5) | 6.36 ± 1.60 | 4.0 ± 0.9 |
MWNT-7 | 0.64 | (5) | 132 ± 140 | 96.3 ± 8.0 | (5) | 73.9 ± 9.4 | 44.1 ± 8.6 |
MWNT-7 | 3.2 | (5) | 754 ± 55.0 | 458.5 ± 40.6 | (0) | – | – |
VGCF™-H | 0.128 | (5) | 21.0 ± 2.60 | 16.2 ± 2.1 | (5) | 9.95 ± 1.8 | 6.3 ± 1.8 |
VGCF™-H | 0.64 | (5) | 129 ± 17.0 | 101.4 ± 12.3 | (5) | 27.1 ± 6.2 | 16.6 ± 4.0 |
VGCF™-H | 3.2 | (5) | 581 ± 61.0 | 422.1 ± 30.0 | (5) | 168.0 ± 154.0 | 106.4 ± 110.8 |